Towards next‐generation TIL therapy: TILs enriched in neoepitope‐specific T cells
Main Authors: | Marion Arnaud, George Coukos, Alexandre Harari |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/ctm2.1174 |
Similar Items
-
Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More Personal
by: Valentina Bianchi, et al.
Published: (2020-06-01) -
Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges
by: Yueshui Zhao, et al.
Published: (2022-08-01) -
Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer
by: Jason M. Redman, et al.
Published: (2023-06-01) -
NMD inhibition by 5-azacytidine augments presentation of immunogenic frameshift-derived neoepitopes
by: Jonas P. Becker, et al.
Published: (2021-04-01) -
Cell Therapy With TILs: Training and Taming T Cells to Fight Cancer
by: Amrendra Kumar, et al.
Published: (2021-06-01)